Patents by Inventor Rebecca Maloney

Rebecca Maloney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20140163119
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 12, 2014
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20140162270
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 12, 2014
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20140162255
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: August 7, 2013
    Publication date: June 12, 2014
    Applicant: Orion Genomics LLC
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20130317125
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: August 7, 2013
    Publication date: November 28, 2013
    Applicant: Orion Genomics LLC
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20130317124
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: August 7, 2013
    Publication date: November 28, 2013
    Applicant: Orion Genomics LLC
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • NOVEL SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINATIONS OF NOVEL AND KNOWN POLYMORPHISMS FOR DETERMINING THE ALLELE-SPECIFIC EXPRESSION OF THE IGF2 GENE
    Publication number: 20130177911
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: March 8, 2013
    Publication date: July 11, 2013
    Applicant: Orion Genomics LLC
    Inventors: Jared ORDWAY, Nathan Lakey, Rebecca Maloney, Theresa Rahlfing
  • Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
    Patent number: 8420315
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: April 16, 2013
    Assignee: Orion Genomics LLC
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • GENE METHYLATION IN CANCER DIAGNOSIS
    Publication number: 20120122090
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: May 17, 2012
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • Novel Single Nucleotide Polymorphisms and Combinations of Novel and Known Polymorphisms for Determining the Allele-Specific Expression of the IGF2 Gene
    Publication number: 20110311967
    Abstract: Single nucleotide polymorphisms and uses for determining the imprinting status of the Insulin Growth Factor-2 gene in a clinical specimen are described.
    Type: Application
    Filed: August 6, 2008
    Publication date: December 22, 2011
    Applicant: Orion Genomics LLC
    Inventors: Jared Ordway, Nathan Lakey, Rebecca Maloney, Theresa Rohlfing
  • GENE METHYLATION IN CANCER DIAGNOSIS
    Publication number: 20110217706
    Abstract: DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer are provided Additionally, methods of identifying differentially methylated DNA biomarker sequences and their use for the detection and diagnosis of cancer are provided.
    Type: Application
    Filed: August 7, 2009
    Publication date: September 8, 2011
    Inventors: Rebecca Maloney, Arief Budiman, Yulia Korshunova, Jared Ordway
  • Gene methylation in cancer diagnosis
    Patent number: 7960112
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cancer.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: June 14, 2011
    Assignee: Orion Genomics LLC
    Inventors: Muhammad A. Budiman, Jeffrey A. Jeddeloh, Rebecca Maloney, Yulia Korshunova
  • COMBINATIONS OF POLYMORPHISMS FOR DETERMINING ALLELE-SPECIFIC EXPRESSION OF IGF2
    Publication number: 20100286926
    Abstract: Combinations of SNPs and reagents for detecting such SNPs, as well as methods of detecting IGF loss-of-imprinting as provided.
    Type: Application
    Filed: February 11, 2010
    Publication date: November 11, 2010
    Applicant: Orion Genomics LLC
    Inventors: Jared Ordway, Rebecca Maloney, Nathan Lakey, Muhammad A. Budiman
  • GENE METHYLATION IN PROSTATE CANCER DIAGNOSIS
    Publication number: 20090176215
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with prostate cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of prostate cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 9, 2009
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • Gene Methylation in Cervical Cancer Diagnosis
    Publication number: 20090170087
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cervical cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cervical cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • Gene Methylation in Head and Neck Cancer Diagnosis
    Publication number: 20090170085
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with head and neck cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of head and neck cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • Gene Methylation In Esophageal Cancer Diagnosis
    Publication number: 20090170086
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with esophageal cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of esophageal cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • GENE METHYLATION IN DIAGNOSIS OF MELANOMA
    Publication number: 20090170083
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with melanoma. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of melanoma.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: Orion Genomics LLC
    Inventors: Muhammad A. Budiman, Jeffrey A. Jeddeloh, Rebecca Maloney, Yulia Korshunova
  • GENE METHYLATION IN CANCER DIAGNOSIS
    Publication number: 20090170088
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: ORION GENOMICS LLC
    Inventors: MUHAMMAD A. BUDIMAN, JEFFREY A. JEDDELOH, REBECCA MALONEY, YULIA KORSHUNOVA
  • GENE METHYLATION IN RENAL CANCER DIAGNOSIS
    Publication number: 20090170082
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with renal cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of renal cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: Orion Genomics LLC
    Inventors: Muhammad A. Budiman, Jeffrey A. Jeddeloh, Rebecca Maloney, Yulia Korshunova
  • GENE METHYLATION IN BLADDER CANCER DIAGNOSIS
    Publication number: 20090170081
    Abstract: The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with bladder cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of bladder cancer.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 2, 2009
    Applicant: Orion Genomics LLC
    Inventors: Muhammad A. Budiman, Jeffrey A. Jeddeloh, Rebecca Maloney, Yulia Korshunova